Taysha Gene Therapies (TSHA)
5.64
-0.02 (0.35%)
Upcoming Events
Latest Headlines
Taysha Gene Therapies (TSHA) PT Raised to $13 at Goldman Sachs
July 21, 2026 6:38 AM - StreetInsider
Form 4 Taysha Gene Therapies, For: Jul 10 Filed by: Nagendran Sukumar
July 10, 2026 6:55 PM - SEC Filing
Form 144 Taysha Gene Therapies, Filed by: Nagendran Sukumar
July 10, 2026 4:22 PM - SEC Filing
Taysha Gene Therapies (TSHA) Reiterated at Market Outperform by Citizens
July 2, 2026 4:19 AM - StreetInsider
Taysha Gene Therapies (TSHA) PT Raised to $15 at Baird
June 29, 2026 1:53 PM - StreetInsider
Form 8-K Taysha Gene Therapies, For: Jun 24
June 25, 2026 4:26 PM - SEC Filing
Form 424B5 Taysha Gene Therapies,
June 25, 2026 4:24 PM - SEC Filing
Taysha Gene Therapies to present TSHA-102 data at 2026 Rett meeting
June 25, 2026 4:01 PM - StreetInsider
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
June 25, 2026 4:01 PM - StreetInsider
Taysha Gene Therapies prices $200M public stock offering
June 24, 2026 10:33 PM - StreetInsider
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 24, 2026 10:33 PM - Globe NewsWire
Form 424B5 Taysha Gene Therapies,
June 24, 2026 5:21 PM - SEC Filing
Taysha Gene Therapies launches $200M stock and warrant offering
June 24, 2026 4:01 PM - StreetInsider
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
June 24, 2026 4:01 PM - StreetInsider
Taysha Gene Therapies (TSHA) PT Raised to $14 at BMO Capital on Differentiation
June 23, 2026 7:00 AM - StreetInsider
Taysha Gene Therapies (TSHA) PT Raised to $11 at Citizens on REVEAL Data Update
June 23, 2026 4:40 AM - StreetInsider
Taysha Gene Therapies (TSHA) PT Raised to $10 at BofA Securities
June 22, 2026 12:27 PM - StreetInsider
Form 8-K Taysha Gene Therapies, For: Jun 22
June 22, 2026 8:15 AM - SEC Filing
Taysha completes dosing in Rett syndrome pivotal trial, reports data
June 22, 2026 8:00 AM - StreetInsider
Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome
June 22, 2026 8:00 AM - StreetInsider
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 5, 2026 8:01 AM - Globe NewsWire
Form 4 Taysha Gene Therapies, For: Jun 01 Filed by: Stalfort John A III
June 2, 2026 4:31 PM - SEC Filing
Form 4 Taysha Gene Therapies, For: Jun 01 Filed by: Sepp-Lorenzino Laura
June 2, 2026 4:31 PM - SEC Filing
Form 4 Taysha Gene Therapies, For: Jun 01 Filed by: Long Alison S
June 2, 2026 4:30 PM - SEC Filing
Form 4 Taysha Gene Therapies, For: Jun 01 Filed by: Donenberg Phillip B.
June 2, 2026 4:30 PM - SEC Filing
Form 8-K Taysha Gene Therapies, For: Jun 01
June 2, 2026 4:06 PM - SEC Filing
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: Vestal Point Capital, LP
May 15, 2026 5:13 PM - SEC Filing
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: RTW INVESTMENTS, LP
May 15, 2026 8:36 AM - SEC Filing
Taysha Gene Therapies (TSHA) PT Raised to $10 at BMO Capital
May 7, 2026 7:46 AM - StreetInsider
Form 10-Q Taysha Gene Therapies, For: Mar 31
May 6, 2026 8:31 AM - SEC Filing
Form 8-K Taysha Gene Therapies, For: May 06
May 6, 2026 8:12 AM - SEC Filing
Taysha Gene Therapies (TSHA) Misses Q1 EPS by 2c
May 6, 2026 8:03 AM - StreetInsider
Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 6, 2026 8:00 AM - Globe NewsWire
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026 4:05 PM - StreetInsider
Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6
April 29, 2026 8:00 AM - Globe NewsWire
Taysha Gene Therapies to present TSHA-102 preclinical data at ASGCT meeting
April 27, 2026 5:21 PM - StreetInsider
Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting
April 27, 2026 5:21 PM - Globe NewsWire
Full Article List
